Maxigen Biotech Aug revenue falls to NT$68.5M vs NT$70.3M
Maxigen Biotech Inc. reported August 2026 revenue of NT$68,526,000 versus NT$70,258,000 in 2025. It also posted Jan-Aug revenue of NT$544,170,000 versus NT$521,741,000.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.